Up-Regulation of GITRL on Dendritic Cells by WGP Improves Anti-Tumor Immunity in Murine Lewis Lung Carcinoma

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Tian, Jie ^a   Ma, Jie ^a   Ma, Ke ^a   Ma, Bin ^a   Tang, Xinyi ^a   Baidoo, Samuel Essien ^a   Tong, Jia ^a   Yan, Jun ^b   Lu, Liwei ^c   Xu, Huaxi ^a   Wang, Shengjun ^a  

^a JIANGSU UNIVERSITY   (China)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; DECTIN 1 RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR LIGAND; LECTIN RECEPTOR; UNCLASSIFIED DRUG; WHOLE BETA GLUCAN PARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOWN REGULATION; DRUG MECHANISM; EFFECTOR CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; UPREGULATION;

EID: 84867546608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046936     Document Type: Article

References (45)

1. Bohn JA, BeMiller JN, (1995) (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydrate Polymers 28: 3-14.
2. Ross GD, (2000) Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein. Crit Rev Immunol 20: 197-222.
3. Brown GD, Gordon S, (2001) Immune recognition: A new receptor for [beta]-glucans. Nature 413: 36-37.
4. Brown GD, Herre J, Williams DL, Willment JA, Marshall ASJ, et al. (2003) Dectin-1 Mediates the Biological Effects of β-Glucans. The Journal of Experimental Medicine 197: 1119-1124.
5. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM, (2003) Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2. The Journal of Experimental Medicine 197: 1107-1117.
6. Zimmerman JW, Lindermuth J, Fish PA, Palace GP, Stevenson TT, et al. (1998) A Novel Carbohydrate-Glycosphingolipid Interaction between a β-(1-3)-Glucan Immunomodulator, PGG-glucan, and Lactosylceramide of Human Leukocytes. Journal of Biological Chemistry 273: 22014-22020.
7. Rice PJ, Kelley JL, Kogan G, Ensley HE, Kalbfleisch JH, et al. (2002) Human monocyte scavenger receptors are pattern recognition receptors for (1⇒" BORDER="0">3)-ß-D-glucans. Journal of Leukocyte Biology 72: 140-146.
8. Herre J, Marshall ASJ, Caron E, Edwards AD, Williams DL, et al. (2004) Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104: 4038-4045.
9. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, et al. (2002) The β-Glucan Receptor, Dectin-1, Is Predominantly Expressed on the Surface of Cells of the Monocyte/Macrophage and Neutrophil Lineages. The Journal of Immunology 169: 3876-3882.
10. Brown GD, (2006) Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol 6: 33-43.
11. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, et al. (2009) Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-[kappa]B activation through Raf-1 and Syk. Nat Immunol 10: 203-213.
12. Reid DM, Gow NAR, Brown GD, (2009) Pattern recognition: recent insights from Dectin-1. Current Opinion in Immunology 21: 30-37.
13. Goodridge HS, Wolf AJ, Underhill DM, (2009) β-glucan recognition by the innate immune system. Immunological Reviews 230: 38-50.
14. Geijtenbeek TBH, Gringhuis SI, (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9: 465-479.
15. Li B, Cai Y, Qi C, Hansen R, Ding C, et al. (2010) Orally Administered Particulate β-Glucan Modulates Tumor-Capturing Dendritic Cells and Improves Antitumor T-Cell Responses in Cancer. Clinical Cancer Research 16: 5153-5164.
16. Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, et al. (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proceedings of the National Academy of Sciences 94: 6216-6221.
17. Ronchetti S, Zollo O, Bruscoli S, Agostini M, Bianchini R, et al. (2004) Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. European Journal of Immunology 34: 613-622.
18. Kanamaru F, Youngnak P, Hashiguchi M, Nishioka T, Takahashi T, et al. (2004) Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells. The Journal of Immunology 172: 7306-7314.
19. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S, (2002) Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3: 135-142.
20. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, et al. (2002) CD4+CD25+ Immunoregulatory T Cells: Gene Expression Analysis Reveals a Functional Role for the Glucocorticoid-Induced TNF Receptor. Immunity 16: 311-323.
21. Nocentini G, Ronchetti S, Cuzzocrea S, Riccardi C, (2007) GITR/GITRL: More than an effector T cell co-stimulatory system. European Journal of Immunology 37: 1165-1169.
22. Stephens GL, McHugh RS, Whitters MJ, Young DA, Luxenberg D, et al. (2004) Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells. The Journal of Immunology 173: 5008-5020.
23. Tone M, Tone Y, Adams E, Yates SF, Frewin MR, et al. (2003) Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proceedings of the National Academy of Sciences 100: 15059-15064.
24. Watts TH, (2005) TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23-68.
25. Ji H-b, Liao G, Faubion WA, Abadía-Molina AC, Cozzo C, et al. (2004) Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression. The Journal of Immunology 172: 5823-5827.
26. Chattopadhyay K, Ramagopal UA, Brenowitz M, Nathenson SG, Almo SC, (2008) Evolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily. Proceedings of the National Academy of Sciences 105: 635-640.
27. Shevach EM, Stephens GL, (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6: 613-618.
28. Nocentini G, Riccardi C (2009) GITR: A Modulator of Immune Response and Inflammation Therapeutic Targets of the TNF Superfamily. In: Grewal IS, editor: Springer New York. pp. 156-173.
29. Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, et al. (1999) ß-Glucan, a "Specific" Biologic Response Modifier That Uses Antibodies to Target Tumors for Cytotoxic Recognition by Leukocyte Complement Receptor Type 3 (CD11b/CD18). The Journal of Immunology 163: 3045-3052.
30. Hong F, Hansen RD, Yan J, Allendorf DJ, Baran JT, et al. (2003) β-Glucan Functions as an Adjuvant for Monoclonal Antibody Immunotherapy by Recruiting Tumoricidal Granulocytes as Killer Cells. Cancer Research 63: 9023-9031.
31. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, et al. (2004) Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models. The Journal of Immunology 173: 797-806.
32. Cheung N-KV, Modak S, (2002) Oral (1→3),(1→4)-β-d-Glucan Synergizes with Antiganglioside GD2 Monoclonal Antibody 3F8 in the Therapy of Neuroblastoma. Clinical Cancer Research 8: 1217-1223.
33. Modak S, Koehne G, Vickers A, O'Reilly RJ, Cheung N-KV, (2005) Rituximab therapy of lymphoma is enhanced by orally administered (1 → 3),(1 → 4)-d-β-glucan. Leukemia Research 29: 679-683.
34. Li B, Allendorf DJ, Hansen R, Marroquin J, Ding C, et al. (2006) Yeast β-Glucan Amplifies Phagocyte Killing of iC3b-Opsonized Tumor Cells via Complement Receptor 3-Syk-Phosphatidylinositol 3-Kinase Pathway. The Journal of Immunology 177: 1661-1669.
35. Xia Y, Vetvicka V, Yan J, Hanikyrová M, Mayadas T, et al. (1999) The ß-Glucan-Binding Lectin Site of Mouse CR3 (CD11b/CD18) and Its Function in Generating a Primed State of the Receptor That Mediates Cytotoxic Activation in Response to iC3b-Opsonized Target Cells. The Journal of Immunology 162: 2281-2290.
36. Allendorf DJ, Yan J, Ross GD, Hansen RD, Baran JT, et al. (2005) C5a-Mediated Leukotriene B4-Amplified Neutrophil Chemotaxis Is Essential in Tumor Immunotherapy Facilitated by Anti-Tumor Monoclonal Antibody and β-Glucan. The Journal of Immunology 174: 7050-7056.
37. LeibundGut-Landmann S, Grosz O, Robinson MJ, Osorio F, Slack EC, et al. (2007) Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8: 630-638.
38. LeibundGut-Landmann S, Osorio F, Brown GD, Reis e Sousa C, (2008) Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 112: 4971-4980.
39. Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, et al. (2006) Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. The Journal of Clinical Investigation 116: 916-928.
40. Karumuthil-Melethil S, Perez N, Li R, Vasu C, (2008) Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes. The Journal of Immunology 181: 8323-8334.
41. Baran J, Allendorf DJ, Hong F, Ross GD, (2007) Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice. Folia Histochem Cytobiol 45: 107-114.
42. Tian J, Ma J, Wang S, Yan J, Chen J, et al. (2011) Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation. Cellular Immunology 270: 183-187.
43. You S, Poulton L, Cobbold S, Liu C-P, Rosenzweig M, et al. (2009) Key Role of the GITR/GITRLigand Pathway in the Development of Murine Autoimmune Diabetes: A Potential Therapeutic Target. PLoS ONE 4: e7848.
44. Cohen AD, Schaer DA, Liu C, Li Y, Hirschhorn-Cymmerman D, et al. (2010) Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation. PLoS ONE 5: e10436.
45. Livak KJ, Schmittgen TD, (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-ΔΔCT Method. Methods 25: 402-408.